BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17784878)

  • 1. Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation.
    Janué A; Olivé M; Ferrer I
    Brain Pathol; 2007 Oct; 17(4):377-88. PubMed ID: 17784878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies.
    Olivé M; van Leeuwen FW; Janué A; Moreno D; Torrejón-Escribano B; Ferrer I
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):76-87. PubMed ID: 17931355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study.
    Claeys KG; van der Ven PF; Behin A; Stojkovic T; Eymard B; Dubourg O; Laforêt P; Faulkner G; Richard P; Vicart P; Romero NB; Stoltenburg G; Udd B; Fardeau M; Voit T; Fürst DO
    Acta Neuropathol; 2009 Mar; 117(3):293-307. PubMed ID: 19151983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies.
    Janué A; Odena MA; Oliveira E; Olivé M; Ferrer I
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):711-23. PubMed ID: 17882015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease.
    Freixes M; Rodríguez A; Dalfó E; Ferrer I
    Neurobiol Aging; 2006 Dec; 27(12):1807-15. PubMed ID: 16310893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of myofibrillar myopathies.
    Ferrer I; Olivé M
    Expert Rev Mol Med; 2008 Sep; 10():e25. PubMed ID: 18764962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene.
    Claeys KG; Fardeau M; Schröder R; Suominen T; Tolksdorf K; Behin A; Dubourg O; Eymard B; Maisonobe T; Stojkovic T; Faulkner G; Richard P; Vicart P; Udd B; Voit T; Stoltenburg G
    Neuromuscul Disord; 2008 Aug; 18(8):656-66. PubMed ID: 18653338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutations.
    von Nandelstadh P; Soliymani R; Baumann M; Carpen O
    Biochem J; 2011 May; 436(1):113-21. PubMed ID: 21361873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myofibrillar myopathies.
    Selcen D
    Curr Opin Neurol; 2008 Oct; 21(5):585-9. PubMed ID: 18769253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different early pathogenesis in myotilinopathy compared to primary desminopathy.
    Fischer D; Clemen CS; Olivé M; Ferrer I; Goudeau B; Roth U; Badorf P; Wattjes MP; Lutterbey G; Kral T; van der Ven PF; Fürst DO; Vicart P; Goldfarb LG; Moza M; Carpen O; Reichelt J; Schröder R
    Neuromuscul Disord; 2006 Jun; 16(6):361-7. PubMed ID: 16684602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.
    Selcen D; Ohno K; Engel AG
    Brain; 2004 Feb; 127(Pt 2):439-51. PubMed ID: 14711882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of caveolar components in primary desminopathy.
    Shinde A; Nakano S; Sugawara M; Toyoshima I; Ito H; Tanaka K; Kusaka H
    Neuromuscul Disord; 2008 Mar; 18(3):215-9. PubMed ID: 18343114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
    Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations.
    Li M; Dalakas MC
    Ann Neurol; 2001 Apr; 49(4):532-6. PubMed ID: 11310634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of mutant myotilins.
    Keduka E; Hayashi YK; Shalaby S; Mitsuhashi H; Noguchi S; Nonaka I; Nishino I
    Am J Pathol; 2012 Apr; 180(4):1570-80. PubMed ID: 22349301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibrillar myopathies.
    Claeys KG; Fardeau M
    Handb Clin Neurol; 2013; 113():1337-42. PubMed ID: 23622358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptocormia as presenting sign in myofibrillar myopathy.
    Renard D; Castelnovo G; Fernandez C; De Paula AM; Penttilä S; Suominen T; Udd B
    Neuromuscul Disord; 2012 Nov; 22(11):987-9. PubMed ID: 22749474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofibrillar myopathies.
    Selcen D
    Curr Opin Neurol; 2010 Oct; 23(5):477-81. PubMed ID: 20664348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibrillar myopathies.
    Selcen D; Engel AG
    Handb Clin Neurol; 2011; 101():143-54. PubMed ID: 21496631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of redox dynamics and desmin post-translational modifications in skeletal muscle models of desminopathies.
    Delort F; Segard BD; Hakibilen C; Bourgois-Rocha F; Cabet E; Vicart P; Huang ME; Clary G; Lilienbaum A; Agbulut O; Batonnet-Pichon S
    Exp Cell Res; 2019 Oct; 383(2):111539. PubMed ID: 31369751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.